NZ334949A - Stabilised pharmaceutical composition of quinupristine and dalfopristine with methanesulphonic acid or hydrochloric acid - Google Patents
Stabilised pharmaceutical composition of quinupristine and dalfopristine with methanesulphonic acid or hydrochloric acidInfo
- Publication number
- NZ334949A NZ334949A NZ334949A NZ33494997A NZ334949A NZ 334949 A NZ334949 A NZ 334949A NZ 334949 A NZ334949 A NZ 334949A NZ 33494997 A NZ33494997 A NZ 33494997A NZ 334949 A NZ334949 A NZ 334949A
- Authority
- NZ
- New Zealand
- Prior art keywords
- quinupristine
- dalfopristine
- pharmaceutical composition
- acid
- hydrochloric acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9614062A FR2755857B1 (fr) | 1996-11-19 | 1996-11-19 | Compositions pharmaceutiques stabilisees, a base de quinupristine et de dalfopristine et leur preparation |
| PCT/FR1997/002047 WO1998022107A1 (fr) | 1996-11-19 | 1997-11-14 | Compositions pharmaceutiques stabilisees, a base de quinupristine et de dalfopristine et leur preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ334949A true NZ334949A (en) | 2000-12-22 |
Family
ID=9497744
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ334949A NZ334949A (en) | 1996-11-19 | 1997-11-14 | Stabilised pharmaceutical composition of quinupristine and dalfopristine with methanesulphonic acid or hydrochloric acid |
Country Status (45)
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2772272B1 (fr) * | 1997-12-16 | 2000-01-14 | Rhone Poulenc Rorer Sa | Compositions pharmaceutiques a base de dalfopristine et de quinupristine et leur preparation |
| US6468967B1 (en) * | 1998-09-25 | 2002-10-22 | Cubist Pharmaceuticals, Incorporated | Methods for administration of antibiotics |
| DK1582204T3 (da) * | 1999-03-03 | 2013-11-04 | Lilly Co Eli | Echinocandin-farmaceutiske formuleringer, der indeholder miceldannende overfladeaktive stoffer |
| TWI233805B (en) * | 1999-07-01 | 2005-06-11 | Fujisawa Pharmaceutical Co | Stabilized pharmaceutical composition in lyophilized form as antifungal agent |
| US6119269A (en) * | 1999-09-23 | 2000-09-19 | Imler; Jack | Fishing vest with removable storage container system |
| US6696412B1 (en) | 2000-01-20 | 2004-02-24 | Cubist Pharmaceuticals, Inc. | High purity lipopeptides, Lipopeptide micelles and processes for preparing same |
| FR2812549B1 (fr) * | 2000-08-03 | 2003-03-21 | Aventis Pharma Sa | Associations dalfopristine/quinupristine avec le cefpirome |
| US20060014674A1 (en) | 2000-12-18 | 2006-01-19 | Dennis Keith | Methods for preparing purified lipopeptides |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2549065B1 (fr) * | 1983-07-13 | 1985-10-25 | Rhone Poulenc Sante | Nouveaux derives de synergistines, leur preparation et les compositions pharmaceutiques qui les contiennent |
| FR2576022B1 (fr) * | 1985-01-11 | 1987-09-11 | Rhone Poulenc Sante | Nouveaux derives de la pristinamycine ii b, leur preparation et les compositions pharmaceutiques qui les contiennent |
| FR2599036B1 (fr) * | 1986-05-22 | 1988-09-09 | Rhone Poulenc Sante | Nouveaux derives de synergistines, leur preparation et les compositions pharmaceutiques qui les contiennent |
-
1996
- 1996-11-19 FR FR9614062A patent/FR2755857B1/fr not_active Expired - Fee Related
-
1997
- 1997-11-13 IN IN3274DE1997 patent/IN187038B/en unknown
- 1997-11-13 PE PE1997001017A patent/PE13999A1/es not_active Application Discontinuation
- 1997-11-14 PL PL97333850A patent/PL190164B1/pl not_active IP Right Cessation
- 1997-11-14 EA EA199900479A patent/EA002025B1/ru unknown
- 1997-11-14 KR KR10-1999-7004364A patent/KR100530836B1/ko not_active IP Right Cessation
- 1997-11-14 CN CNB97198901XA patent/CN1146417C/zh not_active Expired - Fee Related
- 1997-11-14 EP EP97945926A patent/EP0949923B1/fr not_active Expired - Lifetime
- 1997-11-14 CA CA002271095A patent/CA2271095C/fr not_active Expired - Fee Related
- 1997-11-14 PT PT97945926T patent/PT949923E/pt unknown
- 1997-11-14 MY MYPI97005468A patent/MY123805A/en unknown
- 1997-11-14 CZ CZ0174899A patent/CZ299913B6/cs not_active IP Right Cessation
- 1997-11-14 UA UA99052713A patent/UA59376C2/uk unknown
- 1997-11-14 ES ES97945926T patent/ES2179375T3/es not_active Expired - Lifetime
- 1997-11-14 IL IL12960797A patent/IL129607A0/xx not_active IP Right Cessation
- 1997-11-14 HU HU9904327A patent/HUP9904327A3/hu unknown
- 1997-11-14 SK SK660-99A patent/SK284311B6/sk not_active IP Right Cessation
- 1997-11-14 EE EEP199900127A patent/EE03668B1/xx not_active IP Right Cessation
- 1997-11-14 TR TR1999/01096T patent/TR199901096T2/xx unknown
- 1997-11-14 AT AT97945926T patent/ATE223217T1/de not_active IP Right Cessation
- 1997-11-14 DK DK97945926T patent/DK0949923T3/da active
- 1997-11-14 UY UY24780A patent/UY24780A1/es not_active IP Right Cessation
- 1997-11-14 MA MA24866A patent/MA26448A1/fr unknown
- 1997-11-14 AU AU51256/98A patent/AU740291B2/en not_active Ceased
- 1997-11-14 DE DE69715247T patent/DE69715247T2/de not_active Expired - Lifetime
- 1997-11-14 BR BR9713087-7A patent/BR9713087A/pt not_active Application Discontinuation
- 1997-11-14 NZ NZ334949A patent/NZ334949A/xx unknown
- 1997-11-14 JP JP52326598A patent/JP4278115B2/ja not_active Expired - Lifetime
- 1997-11-14 WO PCT/FR1997/002047 patent/WO1998022107A1/fr active IP Right Grant
- 1997-11-14 AP APAP/P/1999/001530A patent/AP998A/en active
- 1997-11-14 RS YUP-224/99A patent/RS49608B/sr unknown
- 1997-11-15 JO JO19971992A patent/JO1992B1/en active
- 1997-11-17 HR HR970615A patent/HRP970615B1/xx not_active IP Right Cessation
- 1997-11-18 DZ DZ970199A patent/DZ2349A1/xx active
- 1997-11-18 TN TNTNSN97184A patent/TNSN97184A1/fr unknown
- 1997-11-19 AR ARP970105410A patent/AR008695A1/es unknown
- 1997-11-19 ZA ZA9710435A patent/ZA9710435B/xx unknown
- 1997-11-19 CO CO97067661A patent/CO4910113A1/es unknown
- 1997-11-19 TW TW086117271A patent/TW474816B/zh not_active IP Right Cessation
- 1997-11-26 SA SA97180645A patent/SA97180645B1/ar unknown
-
1999
- 1999-04-26 IL IL129607A patent/IL129607A/en unknown
- 1999-05-19 US US09/314,070 patent/US5994338A/en not_active Expired - Lifetime
- 1999-05-19 OA OA9900100A patent/OA11047A/fr unknown
- 1999-05-19 BG BG103412A patent/BG63621B1/bg unknown
- 1999-05-19 NO NO992399A patent/NO992399L/no not_active Application Discontinuation
-
2000
- 2000-03-23 HK HK00101793A patent/HK1022832A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA42779C2 (uk) | Фармацевтично стійкий препарат оксалату платини для парентерального застосування | |
| TW326394B (en) | Insulin formulation | |
| IL93360A (en) | Bactericidal/permeability increasing protein or biologically active analogs thereof and pharmaceutical compositions containing them | |
| IL109448A (en) | Risperidone pamoate, its preparation and pharmaceutical compositions containing it | |
| HUP9802287A2 (hu) | Cinkkel és kívánt esetben lizinnel vagy kalciumionnal előkezelt növekedési hormont tartalmazó stabilizált gyógyszerkészítmény | |
| HK1035534A1 (en) | Macrocyclic analogs and methods of their use and preparation | |
| IL133220A0 (en) | Stabilized antibody formulation | |
| NZ332625A (en) | Concentrated antibody preparation containing greater than 100 mg/ml of the antibody | |
| MY114389A (en) | Aqueous risperidone formulations | |
| GR3001185T3 (en) | Stable solid pharmaceutical composition containing ibuprofen and codeine | |
| CZ25398A3 (cs) | Farmaceutický prostředek | |
| NZ334949A (en) | Stabilised pharmaceutical composition of quinupristine and dalfopristine with methanesulphonic acid or hydrochloric acid | |
| UA32523C2 (uk) | Пептиди, які мають високу біологічну активність, та фармацевтична композиція на їх основі | |
| HRP20030002A2 (en) | STABLE GABAPENTIN HAVING pH WITHIN A CONTROLLED RANGE | |
| CA2225963A1 (en) | Transforming growth factor beta crystals | |
| SE9402157L (sv) | Framaceutisk komposition med analgetisk aktivitet | |
| BG103306A (en) | Liquid allendronate compositions | |
| AU618896B2 (en) | Stable solutions of rebeccamycin analog and preparation thereof | |
| EP0492495A3 (en) | Immobilized d-amino acid oxidase and its use for the production of drugs | |
| MD1714F2 (en) | Therapeutical composition in the form of syrup, containing N-acetylcysteine | |
| PL350413A1 (en) | Pharmaceutical effervescent formulation containing metamizol | |
| MY100078A (en) | Improvements relating to the expansion of tobacco. | |
| CA2120751A1 (en) | Trimethoprim oral liquid | |
| WO2000019997A8 (en) | Controlled release dosage from comprising oxybutynin | |
| AU7534787A (en) | Pharmacologically active compounds and use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RENW | Renewal (renewal fees accepted) | ||
| RENW | Renewal (renewal fees accepted) | ||
| RENW | Renewal (renewal fees accepted) |